Synergistic Potential of α-Melanocyte Stimulating Hormone Based Analogues with Conventional Antibiotic against Planktonic, Biofilm-Embedded, and Systemic Infection Model of MRSAACS INFECTIOUS DISEASESIF3.82023-11-271PRE
Binding of cationic analogues of α-MSH to lipopolysaccharide and disruption of the cytoplasmic membranes caused bactericidal action against Escherichia coliSCIENTIFIC REPORTSIF3.92022-02-077OAAI
RNA Sequencing Identifies a Common Physiology in Vancomycin- and Ciprofloxacin-Tolerant Staphylococcus aureus Induced by ileS MutationsANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52020-09-214OAAI
Prevalence and antibiogram of coagulase negative Staphylococci in bioaerosols from different indoors of a university in IndiaBMC MICROBIOLOGYIF4.22020-07-168OAAI
Genetic and Transcriptomic Analyses of Ciprofloxacin-Tolerant Staphylococcus aureus Isolated by the Replica Plating Tolerance Isolation System (REPTIS)ANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52019-02-0122OAAI
In Vitro Tolerance of Drug-Naive Staphylococcus aureus Strain FDA209P to VancomycinANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52017-02-0117OAAI
Differential Adaptive Responses of Staphylococcus aureus to In Vitro Selection with Different Antimicrobial PeptidesANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52013-10-0133OAAI
C-Terminal Amino Acids of Alpha-Melanocyte-Stimulating Hormone Are Requisite for Its Antibacterial Activity against Staphylococcus aureusANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52011-05-0146OAAI